Ultrasound-triggered carrier-free nanoprodrugs activate cGAS-STING pathway to enhance tumor-targeting chemo-immunotherapy

Puntos clave

• Enhanced tumor-targeting capabilities are observed with novel nanoprodrugs, leading to improved therapy effectiveness.
• Activation of the cGAS-STING pathway was significantly increased when ultrasound-triggered nanoprodrugs were utilized.
• A focus on chemo-immunotherapy highlights the innovative use of ultrasound for drug delivery and cancer treatment.
• Research into this method supports developing more effective cancer therapies, though further validation is needed.